Skip to main content
. 2021 Nov-Dec;11(6):599–609. doi: 10.22038/AJP.2021.18526

Figure 2.

Figure 2

The effect of quercetin on escape latency in the 6-OHDA-injected memory impairments in the control, sham, Parkinson's disease (PD) and quercetin 10 (Q10) and 25 mg/kg (Q25)-treated groups (*p<0.05, ***p<0.001, PD vs. sham and control groups, and & p<0.05, &&& p<0.001, Q10 and Q25 vs. PD group). Two-way ANOVA repeated measurements, followed by Tukey’s post hoc tests